Christopher M Florkowski

4.6k total citations
93 papers, 2.8k citations indexed

About

Christopher M Florkowski is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christopher M Florkowski has authored 93 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Christopher M Florkowski's work include Diabetes Management and Research (16 papers), Coenzyme Q10 studies and effects (13 papers) and Acute Myocardial Infarction Research (13 papers). Christopher M Florkowski is often cited by papers focused on Diabetes Management and Research (16 papers), Coenzyme Q10 studies and effects (13 papers) and Acute Myocardial Infarction Research (13 papers). Christopher M Florkowski collaborates with scholars based in New Zealand, Australia and United States. Christopher M Florkowski's co-authors include Peter M. George, Sarah L. Molyneux, Janice Chew‐Harris, Christopher Frampton, Mark Richards, Joanna M. Young, Michael Lever, Russell Scott, Peter M. George and Sandy Slow and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Christopher M Florkowski

91 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M Florkowski New Zealand 23 725 607 415 394 288 93 2.8k
Sheila K. Patel Australia 32 849 1.2× 642 1.1× 301 0.7× 257 0.7× 290 1.0× 92 3.3k
G. Navis Netherlands 18 755 1.0× 662 1.1× 412 1.0× 160 0.4× 307 1.1× 35 5.7k
Daisuke Sugiyama Japan 30 568 0.8× 516 0.9× 558 1.3× 390 1.0× 416 1.4× 131 3.8k
Hans G. Schneider Australia 29 496 0.7× 537 0.9× 333 0.8× 148 0.4× 237 0.8× 147 2.8k
Inge Hamming Netherlands 14 726 1.0× 721 1.2× 357 0.9× 156 0.4× 132 0.5× 21 5.4k
Michael Bennett United Kingdom 23 706 1.0× 346 0.6× 285 0.7× 158 0.4× 286 1.0× 43 2.0k
Dan Liu China 36 470 0.6× 1.0k 1.7× 464 1.1× 454 1.2× 385 1.3× 253 4.4k
Martin H. Kroll United States 27 480 0.7× 463 0.8× 316 0.8× 101 0.3× 393 1.4× 108 2.9k
Martina Zaninotto Italy 37 1.6k 2.2× 669 1.1× 709 1.7× 588 1.5× 769 2.7× 255 4.8k
Tsung‐Hsien Lin Taiwan 32 2.0k 2.8× 550 0.9× 914 2.2× 440 1.1× 225 0.8× 285 3.8k

Countries citing papers authored by Christopher M Florkowski

Since Specialization
Citations

This map shows the geographic impact of Christopher M Florkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M Florkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M Florkowski more than expected).

Fields of papers citing papers by Christopher M Florkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M Florkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M Florkowski. The network helps show where Christopher M Florkowski may publish in the future.

Co-authorship network of co-authors of Christopher M Florkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M Florkowski. A scholar is included among the top collaborators of Christopher M Florkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M Florkowski. Christopher M Florkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pickering, John W., et al.. (2024). Determination of a whole-blood single-test low-risk threshold for a point-of-care high-sensitivity troponin assay. Emergency Medicine Journal. 41(5). 322–323. 3 indexed citations
2.
Slow, Sandy, John Pearson, Christopher M Florkowski, et al.. (2020). Effect of genetic factors on the response to vitamin D3 supplementation in the VIDARIS randomized controlled trial. Nutrition. 75-76. 110761–110761. 7 indexed citations
3.
4.
5.
Aldous, Sally, Mark Richards, Peter M. George, et al.. (2014). Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction. International Journal of Cardiology. 177(1). 182–186. 26 indexed citations
6.
Florkowski, Christopher M, et al.. (2013). Implementation of the HbA1c IFCC unit — from the laboratory to the consumer: The New Zealand experience. Clinica Chimica Acta. 432. 157–161. 2 indexed citations
7.
Cullen, Louise, Sally Aldous, Martin Than, et al.. (2013). Comparison of high sensitivity troponin T and I assays in the diagnosis of non-ST elevation acute myocardial infarction in emergency patients with chest pain. Clinical Biochemistry. 47(6). 321–326. 28 indexed citations
8.
Slow, Sandy, Patricia Priest, Stephen T. Chambers, et al.. (2013). Effect of vitamin D3 supplementation on Staphylococcus aureus nasal carriage: a randomized, double-blind, placebo-controlled trial in healthy adults. Clinical Microbiology and Infection. 20(5). 453–458. 9 indexed citations
9.
Than, Martin, Louise Cullen, Sally Aldous, et al.. (2012). 2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Biomarker. Journal of the American College of Cardiology. 59(23). 2091–2098. 262 indexed citations
10.
Aldous, Sally, Christopher M Florkowski, Peter George, Martin Than, & Ian Crozier. (2010). HIGH SENSITIVITY TROPONIN ASSAYS PREDICT MAJOR ADVERSE EVENTS AT 2 YEARS AND AT LEVELS BELOW THE 99TH PERCENTILE. Journal of the American College of Cardiology. 55(10). A97.E916–A97.E916. 2 indexed citations
11.
Young, Joanna M., Christopher Strey, Peter M. George, et al.. (2008). Effect of Atorvastatin on Plasma Levels of Asymmetric Dimethylarginine in Patients with Non-Ischaemic Heart Failure. European Journal of Heart Failure. 10(5). 463–466. 22 indexed citations
12.
Willis, Jinny, et al.. (2008). All-cause mortality in insulin-treated diabetic patients: A 20-year follow-up. Diabetes Research and Clinical Practice. 80(1). e6–e9. 17 indexed citations
13.
Molyneux, Sarah L., Christopher M Florkowski, Peter M. George, et al.. (2008). Coenzyme Q10. Journal of the American College of Cardiology. 52(18). 1435–1441. 163 indexed citations
14.
Young, Joanna M., Christopher M Florkowski, Sarah L. Molyneux, et al.. (2007). Effect of Coenzyme Q10 Supplementation on Simvastatin-Induced Myalgia. The American Journal of Cardiology. 100(9). 1400–1403. 131 indexed citations
15.
Young, Joanna M., Christopher M Florkowski, Sarah L. Molyneux, et al.. (2006). Abstract 343: Coenzyme Q10 does not Improve Simvastatin Tolerability in Dyslipidemic Patients with Prior Statin-Induced Myalgia. Circulation. 114. 4 indexed citations
16.
Strey, Christopher, Joanna M. Young, Sarah L. Molyneux, et al.. (2004). Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. Atherosclerosis. 179(1). 201–206. 64 indexed citations
17.
Chen, Frank, et al.. (2003). Death Certification and New Zealand Health Information Service (NZHIS) statistics for diabetes mellitus: an under-recognised health problem. Diabetes Research and Clinical Practice. 63(2). 113–118. 14 indexed citations
18.
Florkowski, Christopher M, et al.. (2001). Age at diagnosis, glycaemic control and the development of retinopathy in a population-based cohort of Type 1 diabetic subjects in Canterbury, New Zealand. Diabetes Research and Clinical Practice. 52(2). 125–131. 7 indexed citations
19.
Florkowski, Christopher M, et al.. (1998). Clinical and biochemical outcomes of Type 2 diabetes mellitus in Canterbury, New Zealand: a 6-year cohort study. Diabetes Research and Clinical Practice. 40(3). 167–173. 5 indexed citations
20.
Florkowski, Christopher M, Paul Jennings, B R Rowe, et al.. (1988). Microalbuminuria in diabetic subjects with chronic peripheral neuropathy. Diabetes Research and Clinical Practice. 5(1). 45–48. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheila K. Patel Breakdown of academic impact, for papers by G. Navis Breakdown of academic impact, for papers by Daisuke Sugiyama Breakdown of academic impact, for papers by Hans G. Schneider Breakdown of academic impact, for papers by Inge Hamming Breakdown of academic impact, for papers by Michael Bennett Breakdown of academic impact, for papers by Dan Liu Breakdown of academic impact, for papers by Martin H. Kroll Breakdown of academic impact, for papers by Martina Zaninotto Breakdown of academic impact, for papers by Tsung‐Hsien Lin
Rankless by CCL
2026